These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3035973)

  • 41. [Evolution of canine parvovirus: loss and gain of the feline host].
    Truyen U
    Tierarztl Prax; 1996 Jun; 24(3):316-8. PubMed ID: 8767195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do canine parvoviruses affect canine neurons? An immunohistochemical study.
    Url A; Schmidt P
    Res Vet Sci; 2005 Aug; 79(1):57-9. PubMed ID: 15894025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunologic properties of canine transmissible venereal sarcoma.
    Powers RD
    Am J Vet Res; 1968 Aug; 29(8):1637-45. PubMed ID: 5690687
    [No Abstract]   [Full Text] [Related]  

  • 44. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice.
    Holmes JM
    Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The singular history of a canine transmissible tumor.
    VonHoldt BM; Ostrander EA
    Cell; 2006 Aug; 126(3):445-7. PubMed ID: 16901777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Field evaluation of a canine parvovirus vaccination program, using feline origin modified live virus vaccine.
    Gordon JC; Rogers WA
    J Am Vet Med Assoc; 1982 Jun; 180(12):1429-31. PubMed ID: 6284689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The "other" parvovirus: first description of the minute virus of canines (Canine parvovirus type 1) in Germany].
    Truyen U; Wolf G; Carmichael LE
    Tierarztl Prax; 1996 Oct; 24(5):511-3. PubMed ID: 8999601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of canine parvovirus involved loss and gain of feline host range.
    Truyen U; Evermann JF; Vieler E; Parrish CR
    Virology; 1996 Jan; 215(2):186-9. PubMed ID: 8560765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MALIGNANCY IN A CANINE TRANSMISSIBLE VENEREAL TUMOR.
    PRIER JE; JOHNSON JH
    J Am Vet Med Assoc; 1964 Dec; 145():1092-4. PubMed ID: 14235478
    [No Abstract]   [Full Text] [Related]  

  • 50. Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.
    Yang TJ; Palker TJ; Harding MW
    Cancer Immunol Immunother; 1991; 33(4):255-62. PubMed ID: 2059969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Canine transmissible venereal sarcoma: tumor cell and infiltrating leukocyte ultrastructure at different growth stages.
    Hill DL; Yang TJ; Wachtel A
    Vet Pathol; 1984 Jan; 21(1):39-45. PubMed ID: 6710811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and characteristics of canine transmissible venereal tumours in Grenada, West Indies.
    Kabuusu RM; Stroup DF; Fernandez C
    Vet Comp Oncol; 2010 Mar; 8(1):50-5. PubMed ID: 20230581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of canine transmissible venereal sarcoma.
    Das U; Das AK
    Vet Res Commun; 2000 Dec; 24(8):545-56. PubMed ID: 11305746
    [No Abstract]   [Full Text] [Related]  

  • 55. Anal and perianal transmissible venereal tumour in a bitch.
    Batamuzi EK; Bittegeko SB
    Vet Rec; 1991 Dec 21-28; 129(25-26):556. PubMed ID: 1801407
    [No Abstract]   [Full Text] [Related]  

  • 56. Canine Transmissible Venereal Tumor: Is Its Biological Behavior Changing?
    Duzanski AP; Fêo HB; Montoya LM; Seullner CV; Rocha NS
    Anat Rec (Hoboken); 2017 Jun; 300(6):1009-1010. PubMed ID: 27981811
    [No Abstract]   [Full Text] [Related]  

  • 57. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT).
    Özalp GR; Zik B; Bastan A; Peker S; Özdemir-Salci ES; Bastan I; Darbaz I; Salar S; Karakas K
    Biotech Histochem; 2012 Jul; 87(5):325-30. PubMed ID: 22404564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.
    Beschorner WE; Hess AD; Nerenberg ST; Epstein RB
    Cancer Res; 1979 Oct; 39(10):3920-7. PubMed ID: 476629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation and cultivation of canine transmissible sarcoma cells.
    Okamoto Y; Fujinaga T; Tajima M; Hoshi N; Otomo K; Koike T
    Nihon Juigaku Zasshi; 1988 Feb; 50(1):9-13. PubMed ID: 3361737
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antibodies in venereal sarcoma in dogs].
    Gómez-Estrada H; Hernández-Jauregui P; Arellano-Blanco J; Fernando-Quintero P; Díaz-Esquivel P; Ochoa-Díaz H; Tapia-Arizmendi G
    Arch Invest Med (Mex); 1976; 7(1):1-8. PubMed ID: 1259507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.